HOME › DRUGS › SODIUM NITROPRUSSIDE
ACTIVE SUBSTANCE / INN

SODIUM NITROPRUSSIDE

Brand name(s): SODIUM NITROPRUSSIDE, NIPRIDE RTU IN SODIUM CHLORIDE 0.9%, NIPRIDE, NITROPRESS
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA208923
NDA209387
ACTIVE SUBSTANCE
Sodium Nitroprusside
REGULATORS
FDA
SPONSORS / MAH
EXELA PHARMA, ROCHE, ABBVIE
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NIPRIDENDA017546ROCHEDiscontinued
SODIUM NITROPRUSSIDEANDA207426SAGENT PHARMS INCPrescription
SODIUM NITROPRUSSIDEANDA208923AVET LIFESCIENCESDiscontinued
NIPRIDE RTU IN SODIUM CHLORIDE 0.9%NDA209387EXELA PHARMAPrescription
NIPRIDE RTU IN SODIUM CHLORIDE 0.9%NDA209387EXELA PHARMADiscontinued
NITROPRESSNDA018450ABBVIEDiscontinued

FULL INTELLIGENCE ON SODIUM NITROPRUSSIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →